CanadaBis Capital Inc. (CANB.V)

CAD 0.04

(0.0%)

Gross Profit Summary of CanadaBis Capital Inc.

  • CanadaBis Capital Inc.'s latest annual gross profit in 2023 was 11.78 Million CAD , up 111.47% from previous year.
  • CanadaBis Capital Inc.'s latest quarterly gross profit in 2024 Q3 was 2.04 Million CAD , up 13.93% from previous quarter.
  • CanadaBis Capital Inc. reported a annual gross profit of 5.57 Million CAD in annual gross profit 2022, up 121.42% from previous year.
  • CanadaBis Capital Inc. reported a annual gross profit of 2.51 Million CAD in annual gross profit 2021, up 117.57% from previous year.
  • CanadaBis Capital Inc. reported a quarterly gross profit of 2.62 Million CAD for 2024 Q1, down -24.49% from previous quarter.
  • CanadaBis Capital Inc. reported a quarterly gross profit of 1.9 Million CAD for 2024 Q2, down -27.6% from previous quarter.

Annual Gross Profit Chart of CanadaBis Capital Inc. (2023 - 2017)

Historical Annual Gross Profit of CanadaBis Capital Inc. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 11.78 Million CAD 111.47%
2022 5.57 Million CAD 121.42%
2021 2.51 Million CAD 117.57%
2020 1.15 Million CAD 2572.82%
2019 -46.77 Thousand CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%

Peer Gross Profit Comparison of CanadaBis Capital Inc.

Name Gross Profit Gross Profit Difference
Aequus Pharmaceuticals Inc. 5499.00 CAD -214187.889%
Decibel Cannabis Company Inc. 41.85 Million CAD 71.849%
Delivra Health Brands Inc. 6.39 Million CAD -84.149%
Entourage Health Corp. 3.7 Million CAD -217.817%
Lifeist Wellness Inc. 5.34 Million CAD -120.491%
Cannara Biotech Inc. 27.23 Million CAD 56.726%
Medicure Inc. 13.98 Million CAD 15.765%
PharmaCielo Ltd. -1.36 Million CAD 960.854%
Rubicon Organics Inc. 13.14 Million CAD 10.327%
BioSyent Inc. 25.14 Million CAD 53.133%
Voyageur Pharmaceuticals Ltd. -2185.00 CAD 539399.359%